Pacer US Cash Cows Growth ETF (BUL)

On our desk, we are closely tracking BUL's positioning within the Mid-Cap Blend space. While its 3-year Sharpe ratio of 1.07 easily outpaces the category median of 0.70, the market sentiment is cautious regarding its high portfolio turnover of 105%. That elevated turnover introduces tax costs and execution friction that could erode net returns if growth sectors rotate sharply. Clients like the strict rules-based focus on free cash flow generation, but the sub-$200M AUM size means we have to scale our position entries carefully to avoid liquidity bottlenecks during macro shocks.

Analyzing the risk metrics for BUL, the structural vulnerabilities are clear. Even though the fund boasts a robust 3-year alpha of +2.60, its 5-year downside capture of 110 and maximum drawdown of -26.6% demonstrate that it absorbs heavier losses than peers during rate shocks like the one in 2022. With a Morningstar risk score of 86, it trades as a very aggressive equity vehicle without downside cushioning mechanisms. The concentration in high near-term cash-flow sectors like Consumer Cyclical (29.26%) and Healthcare (27.21%) makes it heavily beholden to domestic economic cycles.

When evaluating how to pitch or model BUL for quantitative strategies, I look closely at the underlying index characteristics. The Pacer US Cash Cows Growth Index exhibits an impressive free cash flow yield of 5.69% compared to the SandP 900 benchmark's 2.70%, alongside a more attractive P/E ratio of 20.90 versus 25.80. However, quantitative analysts must account for the historical divergence: its 10-year return profile trails the category average, indicating that the cash-flow growth screen underperformed during the prolonged low-rate era prior to 2022. It is a potent tool for a late-cycle regime, but factor models must weight its higher volatility appropriately.